Global Autoimmune Disease Diagnosis Market Size 2024, Forecast To 2033
11 Mar, 2024
The autoimmune disease diagnosis market size has witnessed robust growth in recent years, expanding from $5.56 billion in 2023 to $6.05 billion in 2024, marking a compound annual growth rate (CAGR) of 8.7%. The surge in the historical period is attributable to the increasing incidence of autoimmune diseases, the growth of emerging markets, elevated healthcare expenditure, and a high prevalence among women. Anticipated for the forecasted period is a continued strong upward trajectory, reaching $8.36 billion in 2028 at a CAGR of 8.4%. Factors driving this growth include augmented funding for autoimmune diagnostics, accelerated economic expansion, heightened awareness about autoimmune diseases, and ongoing biomarker discovery initiatives. Noteworthy trends in the forecast period encompass strategic partnerships, investments in artificial intelligence companies, collaboration with governmental bodies, and the development of at-home rapid test kits.
Global Autoimmune Disease Diagnosis Market Key Driver
The autoimmune disease diagnosis market has witnessed growth due to a high incidence of autoimmune diseases. In February 2023, Multiple Sclerosis Australia reported a significant increase in Multiple Sclerosis patients in Australia, reaching 33,335 in 2021, marking a 30% rise over the previous four years. This surge in autoimmune diseases globally is a key factor propelling the growth of the autoimmune disease diagnosis market.
Get A Free Sample Of The Global Autoimmune Disease Diagnosis Market ReportGlobal Autoimmune Disease Diagnosis Market Segments
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
By Geography:The regions covered in the autoimmune disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
North America was the largest region in the autoimmune disease diagnosis market in 2023. Western Europe was the second largest region in the autoimmune disease diagnosis market share. The regions covered in the autoimmune disease diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Autoimmune Disease Diagnosis Industry Players
Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMérieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith’s Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Terumo Corporation, Olympus Medical Systems Corporation, Canon Medical Systems Corporation, Hitachi Group, Nihon Koden Corporation, Sanko Manufacturing Co.,Ltd, Fukuda Denshi, Metran Co., Ltd, Shinva Medical Instrument Company Limited, Shandong WeiGao Group Medical Polymer Company Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell - Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Fresenius Medical Care, Novartis, Merck, Bayer, Medtronic, Draegerwerk AG, Getinge Group, Themis Bioscience, Stryker, Apotex, Bausch Health, Pfizer, HYCOR Biomedical, Exagen Inc, Kronus, Inova Diagnostics, Masimo, Teleflex Inc, 3M, Johnson & Johnson, Becton Dickinson, B. Braun Medical Inc, ResMed Inc
Get The Full Global Autoimmune Disease Diagnosis Market Report
Autoimmune Disease Diagnosis Market Overview
Autoimmune diseases diagnosis are the diseases in which the production of antibodies takes place in the body which attacks and destroys own healthy cells in the body. These include Crohn's disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome, and are diagnosed by immunological tests.
Autoimmune Disease Diagnosis Global Market Report 2023 provides data on the global autoimmune disease diagnosis market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The autoimmune disease diagnosis market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.